Equity-only terms for substantial financial backing: no royalties, a 1%–2% stake for qualifying investment, and strict confidentiality and IP protection.
Version v1.0 · Effective on signature
The Confidentiality & Non-Disclosure Agreement is incorporated by reference.
Signing capacity
Choose the capacity that matches your role. The agreement text applies to both.
Company: W.O.M.E.N. Transport, including its owners, affiliates, and successors ("Company").
Counterparty: The investor or strategic partner signing below ("Counterparty").
Platform: The W.O.M.E.N. Transport logistics platform, including its software, data models, workflows, content, features, and future upgrades.
Counterparty desires to provide substantial financial backing and/or strategic support to accelerate the Platform's rollout, product development, marketing, and national partner network. The Company may accept or reject any proposed backing in its sole discretion.
The minimum qualifying investment for this strategic program is $250,000, unless the Company approves a different amount in writing. The exact investment amount, timing, and form (cash, committed capital, or strategic support) will be set forth in Schedule A and the definitive documents.
In consideration of a substantial qualifying investment, the Company may grant Counterparty an equity stake of 1.00% to 2.00% on a fully diluted basis. The exact percentage will be determined by the Company based on the size, timing, and strategic value of the backing, and will be set forth in a definitive stock purchase agreement, SAFE, or membership interest agreement.
No royalties. Counterparty shall not receive any royalty, revenue share, profit participation, commission, or percentage of gross or net sales, now or in the future. Any prior partnership or royalty statement is expressly superseded and has no effect. Counterparty's only economic rights are the equity rights granted in the definitive documents.
The Company's obligations are conditioned on: (a) completion of due diligence; (b) execution of definitive documents; (c) verification that Counterparty is an accredited investor or otherwise qualified under applicable securities laws; (d) approval by the Company's owners or board; (e) no material adverse change; and (f) compliance with this Agreement, including the NDA and IP policy.
Counterparty shall comply with the Confidentiality & Non-Disclosure Agreement (the "NDA") and the Confidentiality & IP Protection Policy, which are incorporated by reference. Counterparty shall not copy, reproduce, reverse engineer, decompile, disassemble, scrape, extract, train AI on, distribute, publish, sell, license, sublicense, or create derivative works from the Platform or any Confidential Information. All intellectual property remains the Company's sole property.
For 24 months after the date of this Agreement, Counterparty shall not, directly or indirectly: (a) circumvent or exclude the Company from any transaction with any customer, carrier, driver, vendor, partner, or prospect disclosed by the Company; (b) solicit or divert any such person or entity for a competing product or service; or (c) solicit or hire any Company employee or contractor. General advertising not targeted at the Company's relationships is permitted.
Counterparty represents and warrants that: (a) it has full power and authority to enter into this Agreement; (b) the investment funds are lawful and not derived from prohibited activities; (c) it is sophisticated and capable of evaluating the risks; (d) it is an accredited investor or otherwise qualified under applicable securities laws; (e) it has no conflict of interest that would impair its obligations; and (f) it will comply with all applicable laws, including anti-corruption, sanctions, and data privacy laws.
This Agreement is not an offer to sell securities. Any equity will be offered only through definitive documents under an applicable exemption from registration. Equity will be restricted, illiquid, and subject to substantial risk, including loss of the entire investment. Counterparty has had the opportunity to consult independent legal, tax, and financial advisors. The Company makes no guarantee of returns, liquidity, or exit.
If Counterparty provides introductions, co-marketing, distribution, advisory, or other strategic support, the parties will describe the scope in a separate written statement of work. Counterparty is not an employee, agent, fiduciary, or legal representative of the Company and has no authority to bind the Company.
This Agreement begins on the date of signature and continues until the earlier of: (a) closing of the definitive investment documents; or (b) 12 months after the date of signature if no closing occurs. The Company may terminate immediately for breach. Confidentiality, IP, non-circumvention, non-solicitation, remedies, and governing law survive termination.
Counterparty acknowledges that a breach may cause irreparable harm. The Company is entitled to injunctive relief, specific performance, and other equitable remedies without posting a bond. To the maximum extent permitted by law, Counterparty shall pay liquidated damages of $250,000 per breach, which the parties agree is a reasonable estimate of harm and not a penalty, plus disgorgement of profits, actual damages if greater, and the Company's reasonable attorneys' fees, costs, and expert fees. Unauthorized copying or distribution may also constitute copyright infringement, exposing Counterparty to statutory damages and attorneys' fees under 17 U.S.C. §§ 504–505, and may constitute a criminal offense under applicable law. The Company may also seek rescission or cancellation of any equity granted in connection with a breach, to the maximum extent permitted by law.
This Agreement is governed by the laws of the Commonwealth of Pennsylvania. The parties consent to the exclusive jurisdiction and venue of the state and federal courts located in Delaware County, Pennsylvania, except that the Company may seek injunctive relief in any court of competent jurisdiction.
This Agreement, together with the NDA, schedules, and definitive documents, is the entire agreement and supersedes all prior discussions, including any prior partnership or royalty statement. It may be amended only in a signed writing. If any provision is unenforceable, the remainder stays in effect. No waiver unless in writing. Counterparty may not assign without the Company's prior written consent. This Agreement may be signed electronically and in counterparts.
Schedule A — Indicative Terms
Investment amount: $______________
Equity stake: ______% (range 1.00%–2.00%)
Form: Cash / committed capital / strategic support
Closing date: ______________
Typing your full legal name below is your electronic signature. Your name, email, company, title, timestamp, and browser details will be saved as a record of acceptance.